Rapid Micro Biosystems Inc (RPID) is a pioneering biotechnology firm dedicated to transforming microbiological quality control within the pharmaceutical and biotechnology sectors. The company leverages cutting-edge automated growth-based microbial detection technologies to enhance the accuracy and efficiency of microbial testing, thereby ensuring stringent product quality and compliance with regulatory standards. Positioned at the forefront of an expanding market that demands swift and dependable quality assurance solutions, Rapid Micro is poised to lead the advancement of innovative testing methodologies critical to maintaining safety and excellence in regulated environments.
| Revenue (TTM) | $33.59M |
| Gross Profit (TTM) | $1.05M |
| EBITDA | $-44.64M |
| Operating Margin | -108.20% |
| Return on Equity | -86.80% |
| Return on Assets | -34.20% |
| Revenue/Share (TTM) | $0.75 |
| Book Value | $0.75 |
| Price-to-Book | 3.39 |
| Price-to-Sales (TTM) | 3.35 |
| EV/Revenue | 3.216 |
| EV/EBITDA | 0.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 37.30% |
| Shares Outstanding | $41.27M |
| Float | $22.38M |
| % Insiders | 9.94% |
| % Institutions | 57.28% |
Volatility is currently expanding